LONG-TERM INDAP THERAPY EFFECTIVENESS AND SAFETY IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
In total, 40 elderly patients with arterial hypertension (AH) were examined. Seventy percent received indap monotherapy (2,5 mg/d), and 30% – combined therapy (indap plus lisinopril). The follow-up period lasted for 12 months. At baseline and after the end of the treatment, all participants underwen...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2009-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1369 |